ARS Pharmaceuticals, Inc.
Edit

ARS Pharmaceuticals, Inc.

https://ars-pharma.com/
Last activity: 21.03.2024
Categories: ProductMedtechTechnologyFoodTechDevelopmentIT
Our mission at ARS Pharmaceuticals is to provide at-risk patients and their families better protection from severe allergic reactions. We are developing a product that patients and their caregivers can use without anxiety or hesitation, confident in the effectiveness of the both product and the ability to administer it. We are developing ARS-1, a novel intranasal epinephrine spray with a unique absorption technology that could be easy-to-use, convenient and more reliable for patients and loved ones at-risk of severe allergic reactions to food, medications and insect bites that could lead to life-threatening anaphylaxis.
Followers
196
Followers
278
Mentions
53
Location: United States, California, San Diego
Employees: 11-50
Total raised: $55M
Founded date: 2015
Twitter
LinkedIn

Investors 3

DateNameWebsite
01.09.2021RA Capital...racap.com
30.08.2023OrbiMedorbimed.co...
15.09.2021SR Onesrone.com

Funding Rounds 1

DateSeriesAmountInvestors
14.10.2021Series D$55M-

Mentions in press and media 53

DateTitleDescriptionSource
21.03.2024ARS Pharmaceuticals Provides Business Update and Reports Fou...Preparing to submit response to the FDA’s CRL for neffy® (epinephrine nasal spray) in Type I allergi...einpresswi...
11.05.2023First epinephrine nasal spray clears key FDA hurdle, promisi...A committee of the Food and Drug Administration's outside advisers voted Thursday in favor of an epi...cbsnews.co...
01.08.2022ARS, Seattle Firm to MergeARS Pharmaceuticals, Inc. is ramped up and ready to go for its expected commercial launch of neffy –...sdbj.com/n...
14.10.2021ARS Pharmaceuticals Raises Series D Funding Round Worth $55M...-connect.or...
14.10.2021ARS Pharma Secures $55M in Series D Funding that will be use...-connect.or...
13.10.2021ARS Pharmaceuticals Raises Series D Funding Round Worth $55M...-connect.or...
13.10.2021ARS Pharma Secures $55M in Series D Funding that will be use...-connect.or...
11.10.2021ARS Pharma Secures $55M in Series D Funding that will be use...-connect.or...
11.10.2021ARS Pharmaceuticals Raises Series D Funding Round Worth $55M...-connect.or...
10.10.2021ARS Pharmaceuticals Raises Series D Funding Round Worth $55M...-connect.or...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In